PerSeptive Biosystems
This article was originally published in The Gray Sheet
Executive Summary
Nets $33.8 mil. from its offering of 2 mil. shares at $18 per share. Alex. Brown & Sons and Cowen & Company were managing underwriters for the offering, which the firm registered on Feb. 11 with the Securities and Exchange Commission. Proceeds will be used for sales and marketing expansion and for research and development of the firm's three core technologies involving the purification and analysis of biomolecules.